Loading...
•
Jun 30, 2024
OPKO Health Q2 2024 Earnings Report
OPKO Health's financial performance decreased due to reduced revenues and increased operating loss, despite non-cash other income.
Key Takeaways
OPKO Health reported a decrease in consolidated total revenues to $182.2 million compared to $265.4 million for the same period in 2023. The operating loss was $61.7 million, a significant change from the $7.0 million operating income in the prior year. Net loss was $10.3 million, or $0.01 per share, compared to a net loss of $19.6 million, or $0.03 per share, in the previous year.
Total revenues decreased to $182.2 million from $265.4 million year-over-year.
Operating loss was $61.7 million, compared to an operating income of $7.0 million in the same quarter last year.
Net loss was $10.3 million, or $0.01 per share, compared to a net loss of $19.6 million, or $0.03 per share, for the 2023 quarter.
Cash and cash equivalents were $40.6 million as of June 30, 2024.
Forward Guidance
OPKO's senior management will provide a business update, discuss second quarter financial results, provide financial guidance and answer questions during a conference call and live audio webcast today beginning at 4:30 p.m. Eastern time.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...